GeNeuro, Servier 'Disappointed' With Mid-Way Phase IIb Multiple Sclerosis Study

Human brain
GeNeuro "Disappointed" With Mid-Way Results For CHANGE-MS Phase IIb Study • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D